| Ane M Shull, CCC-A | |
|
4881 Sugar Maple Dr, 88mdg/sgpo, Wright Patterson Afb, OH 45433-5546 | |
| (937) 904-8392 | |
| Not Available |
| Full Name | Ane M Shull |
|---|---|
| Gender | Female |
| Speciality | Audiologist-hearing Aid Fitter |
| Location | 4881 Sugar Maple Dr, Wright Patterson Afb, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396731311 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 50872 (Texas) | Primary |
| 237600000X | Audiologist-hearing Aid Fitter | 90561 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ane M Shull, CCC-A 10212 Cherry Tree Ter, Centerville, OH 45458-9432 Ph: (937) 885-0491 | Ane M Shull, CCC-A 4881 Sugar Maple Dr, 88mdg/sgpo, Wright Patterson Afb, OH 45433-5546 Ph: (937) 904-8392 |
News Archive
As the COVID-19 pandemic has overwhelmed healthcare systems across the country, doctors have postponed surgery and other treatments for thousands of patients with cancer.
The launch landscape for new pharmaceutical products has shifted dramatically, with physician access and payer influence two of the biggest changes facing launch teams. At the same time, the pressure for successful new products has never been greater with the pharmaceutical industry facing pipeline deficits, patent expirations and increasing development costs.
An index issued Tuesday by the World Economic Forum (WEF) ranked 134 countries according to how much they had reduced gender disparities over the past year in the areas of economic participation, education, political empowerment and health, the New York Times reports.
Eagle Pharmaceuticals, Inc. today announced that it has entered into an agreement with the United States Army Medical Research Institute of Chemical Defense, the nation's leading science and technology laboratory in the area of medical chemical countermeasures research and development, to conduct a study to evaluate the neuroprotective effects of RYANODEX.
› Verified 4 days ago